Walbert Timothy P's Form 4 filing
Horizon Therapeutics Public Ltd Co (HZNP) · filed May 4, 2022
- Accession no.
- 0001209191-22-027083
- Filed
- May 4, 2022
- Trade date
- May 2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.40M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Walbert Timothy PCIK 0001349376 | Director, Officer (Chairman, President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2022 | Ordinary Shares | SSaleDisposed | −13,942 | $95.38 | −$1,329,787.96 | 471,607 | Direct | |
| May 2, 2022 | Ordinary Shares | SSaleDisposed | −7,608 | $96.62 | −$735,084.96 | 463,999 | Direct | |
| May 2, 2022 | Ordinary Shares | SSaleDisposed | −3,450 | $97.43 | −$336,133.5 | 460,549 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.